Need for Pacemaker After Aortic Valve Replacement: Is Removal of Calcifications the Key?

Publication date: February 2020Source: The Annals of Thoracic Surgery, Volume 109, Issue 2Author(s): Francesco Pollari, Theodor Fischlein, Steffen Pfeiffer
Source: The Annals of Thoracic Surgery - Category: Cardiovascular & Thoracic Surgery Source Type: research

Related Links:

Patients with low-flow, low-gradient aortic stenosis (LFLG-AS) who don't show improvement in mitral regurgitation following transcatheter aortic-valve replacement (TAVR) face an increased risk of mortality, according to a substudy of a multicenter registry.Reuters Health Information
Source: Medscape Radiology Headlines - Category: Radiology Tags: Cardiology News Source Type: news
Conclusion: Surgical treatment for NVE is associated with considerable mortality. The in-hospital mortality and 5-year survival rates of this study were 13.8% and 77.2%, respectively. Underlying conditions, including hypertension and ESRD, and urgent surgery were independent risk factors for unfavorable outcomes. PMID: 32090051 [PubMed]
Source: Korean Journal of Thoracic and Cardiovascular Surgery - Category: Cardiovascular & Thoracic Surgery Tags: Korean J Thorac Cardiovasc Surg Source Type: research
Publication date: Available online 24 February 2020Source: Canadian Journal of CardiologyAuthor(s): Harold L. Lazar
Source: Canadian Journal of Cardiology - Category: Cardiology Source Type: research
Authors: Matsumoto Y, Ayani N, Kuwabara K, Ono J, Yamada K, Narumoto J PMID: 32088585 [PubMed - as supplied by publisher]
Source: Asian Journal of Psychiatry - Category: Psychiatry Tags: Asian J Psychiatr Source Type: research
Publication date: Available online 24 February 2020Source: The Annals of Thoracic SurgeryAuthor(s): Paul C. Tang, Nadeen Sarsour, Jonathan W. Haft, Matthew A. Romano, Matthew Konerman, Monica Colvin, Todd Koelling, Keith D. Aaronson, Francis D. Pagani
Source: The Annals of Thoracic Surgery - Category: Cardiovascular & Thoracic Surgery Source Type: research
(Osaka University) Researchers at Osaka University succeed in Japan's first beating-heart surgery to repair a mitral valve without using artificial heart lung apparatus. This approach can avoid complications arising from the use of artificial heart lung apparatus, and more favorable and earlier postoperative recovery is expected.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
Asymptomatic aortic stenosis (AS) is a challenging disease. Until recently, there was no definitive evidence for early intervention in asymptomatic severe AS, and thus guidelines still incorporate symptom status as a key factor in decision-making.1 Recent prospective data, however, have shown that asymptomatic very severe AS should be treated. Kang et  al.2 reported a randomized controlled trial of 145 patients that showed a clear survival benefit for surgical valve replacement in patients with asymptomatic very severe AS (aortic valve area [AVA] ≤ 0.75 cm2 with either peak velocity ≥ 4....
Source: Journal of the American Society of Echocardiography - Category: Cardiology Authors: Tags: Editorial Comment Source Type: research
Transcatheter aortic valve replacement (TAVR) has become the preferred procedure for aortic valve replacement.1 Preprocedural multidetector computed tomographic (MDCT) imaging for aortic root analysis and prosthetic valve sizing is considered standard of care.2 However, the use of iodinated contrast agent during MDCT angiography bears a significant nephrotoxicity risk in patients with chronic severe kidney failure. Three-dimensional (3D) transesophageal echocardiographic (TEE) imaging is considered a valuable alternative for aortic root sizing in this population.
Source: Journal of the American Society of Echocardiography - Category: Cardiology Authors: Tags: Brief Research Communication Source Type: research
ConclusionBoth TTR ‐ and AL‐CA can accompany severe AS. Parameters solely based on ECG and echocardiography allow for the identification of the majority of CA‐AS. In the present cohort, CA did not significantly worsen prognosis 15.3 months after TAVR.
Source: European Journal of Heart Failure - Category: Cardiology Authors: Tags: Research Article Source Type: research
Diagnosis, treatment &management of prosthetic valve thrombosis: the key considerations. Expert Rev Med Devices. 2020 Feb 21;: Authors: Gündüz S, Kalçık M, Gürsoy MO, Güner A, Özkan M Abstract Introduction: Prosthetic heart valve thrombosis is a life-threatening complication after valve replacement surgery. Although subtherapeutic anticoagulation is the main cause, there are many other conventional and esoteric predisposing factors.Areas covered: The etiopathogenesis, diagnosis and management of prosthetic heart valve thrombosis with particular focus on conventional...
Source: Expert Review of Medical Devices - Category: Medical Devices Tags: Expert Rev Med Devices Source Type: research
More News: Cardiovascular & Thoracic Surgery | Heart Valve Surgery